REGN
#244
Regeneron Pharmaceuticals, Inc. - Common Stock
656.1 2 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.05%
Monthly Change
+6.50%
6 month change
-12.41%
Year Change
+19.28%
Previous Close
663.0 9
Open
656.1 1
Low
656.1 1
High
656.1 2
Volume
263
Financials
- Market Capitalization 68.79 B
- Employee 15 K
- Founded 1988
- CEO Leonard Schleifer
- Website www.regeneron.com
- Headquarter New York, United States
- FIGI BBG000C734W3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
18.86
Price to sales ratio
5.59
Dividends per share
0.94
Dividend yield %
0.46
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 127 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 476.31 USD | -0.82% | -8.93% | +5.55% | +2.41% | 120.89 B USD | ||
| 301 |  ARGX argenx SE - American Depositary Shares | 859.43 USD | -1.92% | -5.99% | -2.54% | +53.93% | 53.18 B USD | ||
| 375 |  RVMD Revolution Medicines, Inc. - Common Stock | 184.97 USD | +0.55% | -2.65% | +17.03% | +233.88% | 39.32 B USD | ||
| 387 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 281.26 USD | -2.36% | -11.69% | -2.38% | -9.64% | 37.55 B USD |
Frequently asked questions about Regeneron Pharmaceuticals, Inc. - Common Stock
What is the Regeneron Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) is 656.12. Over the past 24 hours, the stock has changed by -1.05%. Follow the REGN chart for real-time price dynamics.
What is the stock ticker of Regeneron Pharmaceuticals, Inc. - Common Stock?
Regeneron Pharmaceuticals, Inc. - Common Stock trades under the ticker REGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Regeneron Pharmaceuticals, Inc. - Common Stock stock going up?
REGN has changed by -1.94% over the last week, +6.50% over the last month, and +19.28% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Regeneron Pharmaceuticals, Inc. - Common Stock release financial reports?
Yes. You can track Regeneron Pharmaceuticals, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Regeneron Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Regeneron Pharmaceuticals, Inc. - Common Stock reported net income of 727.2 M for the last quarter. The previous quarter showed 844.6 M, which means net income changed by -13.90%.
How many employees does Regeneron Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Regeneron Pharmaceuticals, Inc. - Common Stock has 15.41 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Regeneron Pharmaceuticals, Inc. - Common Stock EBITDA?
Regeneron Pharmaceuticals, Inc. - Common Stock EBITDA is 766.1 M, and its EBITDA margin is 21.25%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Regeneron Pharmaceuticals, Inc. - Common Stock stock?
You can buy Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Regeneron Pharmaceuticals, Inc. - Common Stock stock?
Investing in Regeneron Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the REGN chart and related analysis on metatrader.com as part of your research.